Clinical impact of quality assurance in an organized cervical screening program

Acta Obstetricia et Gynecologica Scandinavica

Volumn 78, Issue 5, 1999, Pages 429-435

  Andrae, Bengt ^a   Smith, Peter ^a  

^a GÄVLE HOSPITAL   (Sweden)

Author keywords

Cervix neoplasms; Mass screening; Quality assurance

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; FEMALE; HEALTH CARE POLICY; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MASS SCREENING; PRIORITY JOURNAL; QUALITY CONTROL; RETROSPECTIVE STUDY; UTERINE CERVIX CANCER;

EID: 0032946613     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1080/j.1600-0412.1999.780516.x     Document Type: Article

References (41)

1. 1. Franco EL, Monsonego J, eds. New developments in cervical screening and prevention. Oxford: Blackwell Science, 1997: 147-239.
2. 2. Koss LG. The Papanicolaou test for cervical cancer detection. A triumph and a tragedy. JAMA 1989; 261: 737-43.
3. 3. Anderson GH, Boyes DA, Benedet JL, LeRiche JC, Matisic JP, Suen KC et al. Organisation and results of the cervical cytology screening programme in British Columbia 1955-85. BMJ 1988; 296: 975-8.
4. 4. Benedet JL, Anderson GH, Matisic JP. A comprehensive program for cervical cancer detection and management. Am J Obstet Gynecol 1992; 166: 1254-9.
5. 5. Kenter GG, Schoonderwald EM, Koelma IA, Arentz N, Hermans J, Fleuren GJ. The cytological screening history of 469 patients with squamous cell carcinoma of the cervix uteri; does interval carcinoma exist? Acta Obstet Gynecol Scand 1996; 74: 400-3.
6. 6. Boyle P, Veronesi U, Tubiana M, Alexander FE, Calais da Silva F, Denis LJ et al. European School of Oncology Advisory Report to the European Commission for the 'Europe Against Cancer Programme' European Code Against Cancer. Eur J Cancer 1995; 31A: 1395-405.
7. 7. Larsen LP, Olesen F. Characteristics of subgroups of attenders and non-attenders in an organised screening programme for cervical cancer. J Med Screen 1996; 3: 133-9.
8. 8. Chamberlain J. Reasons that some screening programmes fail to control cervical cancer. In: Hakama M, Miller AB, Day NE, eds. Screening for cancer of the uterine cervix. Lyon, France: IARC Sci Publ 1986; 76: 161-8.
9. 9. Stenkvist B, Soderstrom J. Reasons for cervical cancer despite extensive screening. J Med Screen 1996; 3: 204-7.
10. 10. Danielsson J, Petterson G, Hesselius I, Stenkvist B. Computer system for gynecological health control. Scand J Soc Med 1974; 2: 93-7.
11. 11. Stenkvist B, Danielsson J, Petterson G. A computer based system for gynecolocical cytology. Scand J Soc Med 1975; 3: 35-9.
12. 12. Hesselius I. Computerized gynecological health surveillance. Thesis. Acta Universitatis Upsaliensis No. 329. Uppsala, 1979.
13. 13. Gustafsson L, Sparen P, Gustafsson M, Wilander E, Bergstrom R, Adami HO. Efficiency of organised and opportunistic cytological screening for cancer in situ of the cervix. Br J Cancer 1995; 72: 498-505.
14. 14. Adami HO, Ponten J, Sparen P, Bergstrom R, Gustafsson L, Friberg LG. Survival trend after invasive cervical cancer diagnosis in Sweden before and after cytologie screening 1960-1984. Cancer 1994; 73(1): 140-7.
15. 15. Lyall H, Duncan ID. Inaccuracy of cytologie diagnosis in high grade squamous intraepithelial lesions (CIN3). Acta Cytol 1995; 39: 50-4.
16. 16. Paterson MEL, Pell KR, Joslin CAF. Cervical smear histories of 500 women with invasive cervical cancer in Yorkshire. BMJ 1984; 289: 896-8.
17. 17. Richart MR, Wright TC. Controversies in the management of low-grade cervical intraepithelial neoplasia. Cancer 1993; 71: 1413-21.
18. 18. Soutter WP, Fletcher A. Invasive cancer of the cervix in women with mild dyskaryosis followed up cytologically. BMJ 1994; 308: 1421-3.
19. 19. Walker EM, Dodgson J, Duncan ID. Does mild atypia on a cervical smear warrant further investigation? Lancet 1986; 2: 672-3.
20. 20. Cruickshank ME, Angus V, Kelly M, McPhee S, Kitchener HC. The case for stopping cervical screening at age 50. Br J Obstet Gynaecol 1997; 104: 586-9.
21. 21. Gustafsson L, Sparen P, Gustafsson M, Pettersson B, Wilander E, Bergstrom R et al. Low efficiency of cytologic screening for cancer in situ of the cervix in older women. Int J Cancer 1995; 63: 804-9.
22. 22. Duncan ID. NHS Cervical Screening Programme. Guidelines for Clinical Practice and Programme Management. Oxford: National Co-ordinating Network. 1992.
23. 23. Nasca PC, Ellish N, Caputo TA. An epidemiologic study of Pap smear screening histories in women with invasive carcinomas of the uterine cervix. NY State J Med 1991; 91: 152-6.
24. 24. Fletcher A. Screening for cancer of the cervix in older women. Lancet 1990; 335: 97-9.
25. 25. Van Weingarden V, Duncan ID. Rationale for stopping cervical screening in women over 50. BMJ 1993; 306: 967-71.
26. 26. Bergström R, Adami HO, Gustafsson L, Ponten J, Sparen P. Detection of preinvasive cancer of the cervix and the subsequent reduction in invasive cancer. J Natl Cancer Inst 1993; 85: 1050-7.
27. 27. Gram IT, Macaluso M, Stalsberg H. Incidence of cervical intraepithelial neoplasia grade III and cancer of the cervix uteri following a negative Pap-smear in an opportunistic screening. Acta Obstet Gynecol Scand 1998; 77: 228-32.
28. 28. Last JM, ed. A dictionary of epidemiology. 3rd ed. New York: Oxford University Press, 1995: 52.
29. 29. Soutter WP, de Barros Lopes A, Fletcher A, Monaghan JM, Duncan ID, Paraskevaidis E et al. Invasive cervical cancer after conservative therapy for cervical intraepithelial neoplasia. Lancet 1997; 349: 978-80.
30. 30. Sigurdsson K. Effect of organized screening on the risk of cervical cancer. Evaluation of screening activity in Iceland 1964-1991. Int J Cancer 1993; 54: 563-70.
31. 31. Hakama M, Louhivuori K. A screening programme for cervical cancer that worked. Cancer Surv 1988; 7: 403-16.
32. 32. Anderson GH, Benedet JL, Le Riche JC, Matisic JP, Thompson JE. Invasive cancer of the cervix in British Columbia: a review of the demography and screening histories of 437 cases seen from 1985-1988. Obstet Gynecol 1992; 80: 1-4.
33. 33. Sigurdsson K. Quality assurance in cervical cancer screening: the Icelandic experience 1964-1993. Eur J Cancer 1995; 31A: 728-34.
34. 34. Nieminen P, Kallio M, Hakama M. The effect of mass screening on incidence and mortality of squamous and adenocarcinoma of cervix uteri. Obstet Gynecol 1995; 85: 1017-21.
35. 35. Bjerre B, Johansson S. Invasive cervical cancer in a cytologically screened population. Acta Obstet Gynecol Scand 1983; 62: 569-74.
36. 36. Helm G, Johnsson JE, Lindberg LG. The impact of cytological screening on the incidence of invasive cervical cancer. Acta Obstet Gynecol Scand 1980; 59: 271-3.
37. 37. Coleman D, Day N, Douglas G, Farmery E, Lynge E, Philip J et al. Europe Against Cancer Programme. European guidelines for quality assurance in cervical cancer screening. Eur J Cancer 1993; 29A suppl 4: S1-38.
38. 38. Monsonego J, ed. Cervical cancer control joint international meeting. General statements and guidelines. Paris: EUROGIN Sci publ 1997: 18-19.
39. 39. Westin O, Sundman L. Hälsa och sjukdom i Gävleborgs län (Health and disease in the county of Gävleborg) (in Swedish). Department of Public Health Medicine, County Council of Gävleborg 1992; 4.
40. 40. Cancer incidence in Sweden 1991. Swedish National Board of Health and Welfare, 1994: 13-15.
41. 41. Editorial. Cancer of the cervix: Death by incompetence. Lancet 1985; 2: 363-4.